临床试验

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men

NCT：NCT04838769 · ACTIVE_NOT_RECRUITING

NCT编号NCT04838769

状态ACTIVE_NOT_RECRUITING

开始日期2021-09-15

SponsorBoston Scientific Corporation (INDUSTRY)

First posted2021-04-09

Last updated2026-09-14

简要摘要

The study objective is to compare water vapor thermotherapy with the REZŪM™ System to dual drug therapy for the treatment of symptomatic benign prostatic hyperplasia refractory to alpha-blocker monotherapy in sexually active men.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。